[ad_1] HMR59 targets geographic atrophy: a severe form of advanced AMD. In geographic atrophy, complement overactivity destroys cells in the macula, the central part of the retina responsible for central vision and fine detail vision, progressing to blindness. Patients with AMD often have low levels of the CD59 protein, which …
Read More »Experimental gene therapy may be effective for MND patients with a recently discovered gene mutation
[ad_1] Researchers from the Neuroscience Institute of the University of Sheffield in the UK have identified a new genetic risk factor for motor neuron disease (MND) in so-called “junk DNA”. The recently discovered genetic changes are present in up to 1% of patients with MND. The research, published in the …
Read More »